Viewing Study NCT04048265



Ignite Creation Date: 2024-05-06 @ 1:32 PM
Last Modification Date: 2024-10-26 @ 1:15 PM
Study NCT ID: NCT04048265
Status: COMPLETED
Last Update Posted: 2020-04-15
First Post: 2019-08-06

Brief Title: TMS Treatment in Parkinsons Disease With Pain
Sponsor: Xuanwu Hospital Beijing
Organization: Xuanwu Hospital Beijing

Study Overview

Official Title: Study of rTMS in the Treatment of EarlyModerate Parkinsons Disease With Pain
Status: COMPLETED
Status Verified Date: 2019-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: TMSPDP
Brief Summary: Transcranial magnetic stimulation TMS is a procedure that has been shown to improve pain in chronic sufferers It is a well-tolerated procedure that can be performed on an outpatient basis It uses a plastic covered coil that sends a magnetic pulse through the skull into the brain and by targeting particular areas in the brain it can be used to help modulate the perception of pain

The study intends to use this technique to treat such a disabling symptom in patients who suffer from Parkinsons Disease PD Initially the aim is to study this technique in 48 patients who are suffering from pain and have PD These patients would require an EEG before and after the stimulation The stimulation would be performed over ten sessions and the patients would be assessed by a clinician using well recognized clinical tools

It is anticipated that there will be a meaningful improvement in pain It is also anticipated that TMS is a safe technique to use in patients with PD The study will be used to help plan a future study that compares TMS with sham technique to prove whether TMS could be an option in the treatment of such a disabling condition
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None